Cyberdyne CEO Visits Pittsburgh, Highlighting Innovation in Robotics, Aging and Health Tech

Type: News

Focus Area: Patient Safety

Dr. Yoshiyuki Sankai, founder and CEO of Cyberdyne Inc., a global leader in robotic exoskeletons and human-assistive technologies, visited Pittsburgh December 16–17, for a series of high-profile engagements with Carnegie Mellon University, the University of Pittsburgh, healthcare innovators, and regional technology partners. The visit underscored Pittsburgh’s growing role as a hub for robotics, aging-technology research, and policy innovation.

During his visit, Dr. Sankai toured cutting-edge robotics facilities, participated in faculty and policy roundtable discussions on the adoption of robotics in society, observed lab demonstrations focused on assistive and neural technologies, and engaged with industry and ecosystem partners. Cyberdyne’s Hybrid Assistive Limb (HAL) exoskeleton technology was a central focus, particularly in discussions related to mobility, rehabilitation, and aging-in-place solutions.

The visit built on recent cross-sector international collaboration efforts aligned with Dr. Sankai’s work and broader global innovation trends. Recently, the Jewish Healthcare Foundation and Pittsburgh Regional Health Initiative led a multi-sector delegation to Japan to explore Society 5.0, Japan’s national vision for a human-centered society that integrates advanced technologies such as artificial intelligence, robotics, and big data to address demographic challenges, including population aging.